Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
81 studies found for:    Atherosclerosis OR arteriosclerosis OR hardening of the arteries | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Cardiovascular Disease Screening
Conditions: Congenital Heart Disease;   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction;   Acquired Heart Disease
Intervention:
22 Recruiting Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Conditions: Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:
23 Not yet recruiting Dyslipidemia of Obesity Intervention in Teens
Conditions: Dyslipidemia;   Obesity
Interventions: Drug: Pitavastatin;   Drug: Placebo
24 Recruiting Cardiovascular Disease Study
Condition: Spinal Cord Injury
Interventions: Procedure: 2 hour Oral Glucose Tolerance Test;   Procedure: Fat Meal Test
25 Recruiting Platelet Activity in Vascular Surgery and Cardiovascular Events
Conditions: Cardiovascular Disease;   Peripheral Artery Disease;   Critical Limb Ischemia
Intervention:
26 Recruiting Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Conditions: Vascular Inflammation;   Atherosclerotic Cardiovascular Disease
Interventions: Drug: Low dose methotrexate;   Drug: Placebo
27 Recruiting Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Condition: Systemic Lupus Erthematosus
Interventions: Radiation: PET/CT;   Drug: Pioglitazone;   Procedure: Vascular function studies
28 Recruiting Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
Intervention:
29 Recruiting Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
Condition: Cognitive Manifestations
Intervention:
30 Recruiting Metformin in Kidney Disease
Conditions: Chronic Kidney Disease;   Cardiovascular Disease;   Metabolic Syndrome
Interventions: Drug: metformin;   Drug: Placebo
31 Recruiting The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk
Condition: Cardiovascular Disease
Intervention: Other: Observation of SAA on apoB containing lipoproteins
32 Not yet recruiting Skin Sympathetic Nerve Activity and Cardiac Arrhythmias
Condition: Sympathetic Nerve Activity
Intervention: Other: Physiologic maneuvers
33 Recruiting Ugandan Non-Communicable Diseases and Aging Cohort
Conditions: HIV;   Cardiovascular Disease;   Chronic Obstructive Pulmonary Disease;   Atherosclerosis;   Hypertension;   Diabetes Mellitus
Intervention: Other: This is an observational study only
34 Recruiting ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study
Conditions: Cardiovascular Disease;   Coronary Artery Calcification
Intervention:
35 Recruiting Technical Development of Cardiovascular Magnetic Resonance Imaging
Condition: Peripheral Artery Disease
Intervention: Procedure: MRI
36 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
Intervention:
37 Recruiting Endothelial Function and Vein Graft Remodeling
Conditions: Peripheral Arterial Disease;   Cardiovascular Disease
Intervention:
38 Recruiting Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II
Condition: Acute Coronary Artery Syndrome
Interventions: Procedure: Percutaneous coronary intervention;   Procedure: Intravascular ultrasound with virtual histology;   Drug: Atorvastatin or other equivalent dose statin;   Device: LDL-apheresis
39 Recruiting Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
Conditions: Peripheral Artery Disease;   Vascular Disease;   Critical Limb Ischemia
Interventions: Drug: Dexamethasone infusion;   Device: Drug coated balloon
40 Recruiting Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Condition: Peripheral Arterial Disease
Interventions: Drug: Placebo + background APT + SMT;   Drug: Vorapaxar 2.08 mg/d + background APT + SMT.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.